Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | COL6A2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | AVPI1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | LPAR5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RPS6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | HIST2H2AA4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | DAB1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SET | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | NUCKS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PDSS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | METAP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |